Synvisc

Synvisc and Synvisc-One contain the active ingredient hylan G-F 20, a hyaluronic acid-based substance that naturally occurs in the synovial fluid of joints. These injections are used to treat osteoarthritis and other degenerative joint diseases, particularly in patients who have not responded adequately to conservative therapies. The goal of Synvisc® and Synvisc-One is to alleviate joint pain, improve joint mobility, and provide lubrication and cushioning for the joints. The injections must be administered by a specialist to ensure proper technique and treatment efficacy. Both injections can be administered in a series or as a single treatment, depending on the specific product. Synvisc® and Synvisc-One are sterile, high-molecular-weight fluids that help restore joint elasticity and viscosity. The treatments serve as temporary replacements and supplements for joint fluid. The injections act as lubricants and shock absorbers in the joints, reducing pain and improving joint function. Their pain-relieving effects typically last up to six months, though results may vary from patient to patient.